LEVETIRACETAM DEXCEL 250

国: イスラエル

言語: 英語

ソース: Ministry of Health

有効成分:

LEVETIRACETAM

から入手可能:

DEXCEL PHARMA TECHNOLOGIES LTD

ATCコード:

N03AX14

医薬品形態:

TABLETS

構図:

LEVETIRACETAM 250 MG

投与経路:

PER OS

処方タイプ:

Required

製:

DEXCEL LTD, ISRAEL

治療群:

LEVETIRACETAM

治療領域:

LEVETIRACETAM

適応症:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

承認日:

2018-03-31